Drug profile · INN
degarelix
FIRMAGON 120MG
degarelix (FIRMAGON 120MG) is a gonadotropin-releasing hormone receptor antagonist. Associated with Ferring Pharmaceuticals.
EMA: approved TGA: approved Antineoplastic and immunomodulating agents (L02) L02BX02
Patents linked 0
Pipeline programs 13
News articles 0
Drug details — degarelix
- Class
- Antineoplastic and immunomodulating agents (L02)
- Route
- —
- Patents
- 0
- Programs
- 13
- Data quality
- 0.83
Quick answer
degarelix (FIRMAGON 120MG) is a gonadotropin-releasing hormone receptor antagonist. Associated with Ferring Pharmaceuticals.
Key facts
INN degarelix
Brand FIRMAGON 120MG
Mechanism Gonadotropin-releasing hormone receptor antagonist
Therapeutic class Antineoplastic and immunomodulating agents (L02)
ATC code L02BX02
Originator Ferring Pharmaceuticals
Mechanism of action
Gonadotropin-releasing hormone receptor antagonist
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is degarelix?
degarelix (FIRMAGON 120MG) is a gonadotropin-releasing hormone receptor antagonist. Associated with Ferring Pharmaceuticals.
What is the brand name for degarelix?
FIRMAGON 120MG is a marketed brand name for degarelix. Check FDA Drugs@FDA for the current US label holder and prescribing information.